市場調查報告書
商品編碼
1483135
脈搏血氧儀市場評估:依產品類型、技術類型、設備類型、年齡層、最終用戶和地區劃分的機會和預測(2017-2031)Pulse Oximeter Market Assessment, By Product Type, By Technology Type, By Device Type, By Age-Group, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
根據預測,全球脈搏血氧計市場規模將從2023年的27.8億美元成長到2031年的49億美元,2024年至2031年的預測期內複合年增長率為7.33%。近年來,市場經歷了顯著成長,預計未來將保持強勁的擴張速度。
由於人口老化、技術進步、呼吸系統和心血管疾病盛行率增加以及整體人口增長等因素,脈搏血氧儀市場可能會進一步擴大。行業領導者和醫療保健提供者合作,為患者提供最好的工具和解決方案。公共和商業組織都在籌集資金並進行大量投資,以提供優質的解決方案。
呼吸道疾病盛行率增加:
脈搏血氧儀用於治療慢性阻塞性肺病(COPD)、氣喘、氣管插管、心臟驟停、手動鎮靜、呼吸系統疾病、急性呼吸窘迫症候群(ARDS)、睡眠障礙/睡眠呼吸中止症和紫紺心臟。氣喘發生率呈上升趨勢,特別是在亞洲中低收入國家。例如,預計2022年印度將有3,400萬名氣喘患者,佔全球負擔的13.09%。
技術進步和便捷訪問推動市場成長:
隨著技術發展提高了可及性和易用性,脈搏血氧計市場發生了巨大變化。此外,感測器變得越來越小,脈搏血氧計也越來越輕,可以在家中或在旅途中使用。這些發展提高了準確性和可靠性,從而實現準確的測量和可靠的結果。透過整合無線網路和智慧型手機應用程序,脈搏血氧計的實用性和簡單性得到了進一步提高,允許追蹤、分析數據並與醫療專業人員共享數據。該領域還有可能受益於新興技術,例如使用人工智慧演算法結合脈搏血氧飽和度數據來幫助改善患者治療效果和遠端患者監測。在整個預測期內,與自動化、安全性和精度相關的技術進步預計將推動市場擴張。
該報告調查了全球脈搏血氧儀市場,並提供了市場定義和概述、市場規模趨勢和預測、各個細分市場和地區的詳細分析、行業結構、影響市場成長的因素分析以及案例研究。簡介等
Global pulse oximeter market is projected to witness a CAGR of 7.33% during the forecast period 2024-2031F, growing from USD 2.78 billion in 2023 to USD 4.9 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.
A pulse oximeter is a medical device or a non-invasive, discrete tool that monitors blood oxygen saturation fluctuations. It is available in many styles and designs, including fingertip, wrist-worn, bedside/tabletop, and portable oximeters. These styles are commonly used and are always in high demand for their advanced features and ease of carrying. Unlike analog meters, they show additional diagnostic information and oxygen levels by measuring readings using infrared light.
The market for pulse oximeters is anticipated to expand significantly in the upcoming years. This market has the potential to expand even more due to several factors, including an aging population, technology advancements, increased prevalence of respiratory and cardiovascular disorders, and an overall increasing population. Industry giants and healthcare practitioners collaborate to provide patients with the best tools and cosmetic solutions. Both public and commercial organizations are raising money and investing a sizable sum to provide quality solutions. These massive corporations use strategic maneuvers like collaborations, investments, and mergers and acquisitions when they are striving to develop or introduce a new product. For example, in May 2022, Medtronic Plc introduced the Nellcor Oxysoft spO2 sensor, the first pulse oximetry sensor that uses silicon adhesive to protect sensitive skin and improve signal capture and repositionability. Clinicians can make fast judgments for their critically ill patients with the help of this new sensor.
Increasing Prevalence of Respiratory Disorders
Pulse oximeters have a broad range of applications in a variety of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, endotracheal intubation, cardiac arrest, procedural sedation, respiratory complaints, acute respiratory distress syndrome (ARDS), sleep disorders/sleep apnea, and shunts in cyanotic heart disease. A primary factor contributing to the rising need for pulse oximeters in both developed and developing nations is the pervasiveness of long-term respiratory conditions such asthma, COPD, and obstructive sleep apnea (OSA). Instances of asthma are noticeably rising in low- and middle-income nations, especially in Asia. For instance, in 2022, 34 million individuals in India with asthma were anticipated, and they accounted for 13.09% of the worldwide burden. COPD is the third most common cause of death globally, accounting for nearly 3.2 million deaths worldwide. Such factors are expected to expand the market shares of pulse oximetry market.
The market is anticipated to be driven by the rising prevalence of chronic respiratory conditions such cystic fibrosis, asthma, sleep apnea, COPD, and other respiratory infections. Pulse oximeters are a reliable tool for measuring blood oxygen levels in patients with asthma and COPD since oxygen saturation is a crucial criterion in managing these illnesses. With over 12.5 million identified cases and many undiagnosed instances, COPD is the biggest cause of death in the United States, according to an article published by the American Lung Association in 2024. The market for pulse oximeters is expanding due to several factors, one of which is the increased global prevalence of respiratory conditions like pneumonia, asthma, and COPD. People are increasingly realising how crucial it is to keep an eye on their oxygen saturation levels to stay healthy. Additionally, technological developments like mobile applications and wireless connectivity are improving the user experience by providing ease and accessibility to users.
Technological Advancements and Easy Accessibility Drive Market Growth
The market for pulse oximeters has changed dramatically because of technological developments, which have improved accessibility and use. Additionally, introducing small and lightweight pulse oximeters that can be used at home or on the road results from the miniaturization of sensors. These developments have enhanced accuracy and dependability, giving users accurate readings and trustworthy outcomes. The utility and simplicity of pulse oximeters have been further improved by incorporating wireless networking and smartphone applications, which allow for data tracking, analysis, and sharing with healthcare specialists when needed. Pulse oximeters are becoming more widely available to a wider range of consumers due to their improved usability, affordability, and accessibility, propelling the market to uptake these devices. The sector may benefit from emerging technology, such as using artificial intelligence (AI) algorithms to combine pulse oximetry data for better patient outcomes and remote patient monitoring. Technological advances related to automation, safety, and accuracy throughout the projected period are anticipated to propel market expansion. Manufacturers are creating automated, wireless, and remote oximeters for self-monitoring to cut down on hospital stays and doctor visits.
For instance, Smart Meter, a manufacturer, and supplier of patient monitoring devices, launched its iPulseOx in 2022. It offers real-time patient monitoring for long-term conditions and is the first-ever cellular-connected pulse oximeter. This product launch has not only improved the quality of technology in this market but has also given the company a competitive advantage over others in this market.
Increasing Demand for Portable Oximeters Fuels Market Growth
Portable and transportable pulse oximeters are becoming increasingly popular for use in home healthcare. A rise in aging population, combined with their vulnerability to respiratory conditions, is driving expansion in the market. In addition, pulse oximeters come in handy in clinics and hospitals, and their dependency is growing, especially for patients in critical care. Pulse oximeters are being used in aviation and sports medicine because of how compact they are and how quickly they show results. The comfort offered by handheld and wearable oximeters is unparalleled. Easy to carry and manage, these oximeters are lightweight and sleek. The increasing application of pulse oximeters in remote patient monitoring systems is also propelling the market. In addition, the general public's growing emphasis on health and fitness has increased the demand for pulse oximeters. Pulse oximeters are becoming more and more important as tools for athletes, fitness enthusiasts, and those who engage in physical activity to check their oxygen levels while working out. They can enhance their workout performance, avoid overdoing it, and stay safe by continuously checking their oxygen saturation. With the instant feedback that pulse oximeters provide, users can decide on the appropriate level of intensity of their exercise and can make the required modifications. Use of pulse oximeters as vital instruments in the fitness and wellness industry has surged, driving market growth, because of the rising emphasis on maintaining peak fitness levels and prioritising overall well-being.
For example, the Garmin Vivosmart 5 fitness band was introduced in India in June 2022. The new fitness tracker includes features for tracking women's health, heart rate, body battery energy, step count, calorie count, stress, and blood oxygen level.
North America to Dominate the Global Pulse Oximeter Market
North America is anticipated to dominate the global pulse oximeter market and has a sizeable market for smart pulse oximeters because of its improved healthcare infrastructure and the presence of major industry participants. As per the July 2022 report from the Centers for Disease Control and Prevention (CDC), over 805,000 Americans suffer from a heart attack every year. As cardiovascular problems become more common, there will likely be a greater need for pulse oximeters, which will benefit the industry. The market is expanding because of support from regulatory authorities. For example, in June 2023, the Food and Drug Administration (FDA) approved Owlet, a Utah-based healthcare firm, for their baby pulse oximetry featuring its wire-free sock design. BabySat monitors a baby's heart rate and oxygen saturation level using pulse oximetry technology. It notifies carers when a reading deviates from the recommended ranges. Due to the rising prevalence of heart illnesses, which are mostly brought on by sedentary lifestyles and the growing geriatric population in the area, the market is expected to grow profitably for the forecast period.
Future Market Scenario (2024-2031F)
One of the main factors contributing to the anticipated growth of the pulse oximeter market is the increasing population, which will continue to grow in the future, and awareness and desire in people to have the best designs of the most advanced devices in the form of watches or wrist bands. Technology is advancing, and various oximeters are integrated aesthetically into devices like watches and mobiles, so it is a promising factor for this market. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, Masimo launched MightySat, the first ever FDA-approved over the counter (OTC) fingertip pulse oximeter that can be used without any medical prescription.
Key Players Landscape and Outlook
Several companies, such as Medtronic Plc, Masimo Corporation, Nonin Medical Inc, GE HealthCare Technologies, Inc., Contec Medical Systems Co., Ltd., OSI Systems, Inc., Omron Corporation, Koninklijke Philips N.V, Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, and ICU Medical, are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed pulse oximeters, to help researchers and to bring up their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.
Collaboration between Masimo Corporation and GE HealthCare Technologies, Inc. to incorporate patient monitoring technology was recently revealed. The goal of the partnership is to incorporate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's wearable, wireless patient monitoring system, Portrait Mobile. Cloud-native technology powers Portrait Mobile, an internet of medical things (IoMT) platform. It offers a complete wearable, continuous monitoring experience. In August of this year, Portrait Mobile received FDA approval.
To enhance the treatment of chronic illnesses, Nonin Medical and Medixine have partnered to offer remote patient monitoring for their pulse oximetry devices. The partnership aims to meet the rising need for digital health solutions, especially in the United States. By combining Nonin's pulse oximeters with Medixine's software platform, doctors will have easier patient data access, expediting diagnosis and treatment. The cooperation intends to enhance nightly oximetry tests by digitising healthcare services, perhaps cutting down on months-long procedures to a single night and providing patients with chronic disorders like sleep apnea with more effective care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.